Guardant Health, Inc. reported $1.18B of revenue over the trailing twelve months, +43% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.18B (to Q2 2026). Net Income: −$453M, trailing twelve months to Q2 2026. Free Cash Flow: −$241M, trailing twelve months to Q2 2026. Op Margin: −40%, trailing twelve months to Q2 2026.

GHGuardant Health, Inc.

HealthcareUSD

$170.77

$54.2352 weeks$170.77

GH as reported

Guardant Health, Inc. reported $1.18B of revenue over the trailing twelve months, +43% on the year before. 10 reported series are charted on this page, each one as filed.

$1.18B

Revenue, trailing twelve months · to Q2 2026 · +43% against the twelve months before

Net Income: −$453M
Net Income · +9.6% year on year · trailing twelve months to Q2 2026
Free Cash Flow: −$241M
Free Cash Flow · −11% year on year · trailing twelve months to Q2 2026
Op Margin: −40%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for GH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.18B	+43%	Q2 2026
Net Income	−$453M	+9.6%	Q2 2026
EPS	−$3.49	+4.2%	Q2 2026
Gross Margin	65%	n/a	Q2 2026
Op Margin	−40%	n/a	Q2 2026
Net Margin	−38%	n/a	Q2 2026
ROE	244%	n/a	Q2 2026
ROA	−25%	n/a	Q2 2026
ROIC	−172%	n/a	Q2 2026
Free Cash Flow	−$241M	−11%	Q2 2026